CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 152816-152994 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T953","span":{"begin":0,"end":178},"obj":"Sentence"},{"id":"T96401","span":{"begin":0,"end":178},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A phase II treatment trial of patients with natural colds with symptoms of less than 36 h was conducted in which patients received ruprintrivir BID or TID or placebo for 10 days."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T21","span":{"begin":0,"end":178},"obj":"Sentence"}],"text":"A phase II treatment trial of patients with natural colds with symptoms of less than 36 h was conducted in which patients received ruprintrivir BID or TID or placebo for 10 days."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T821","span":{"begin":90,"end":93},"obj":"Disease"}],"attributes":[{"id":"A821","pred":"mondo_id","subj":"T821","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"A phase II treatment trial of patients with natural colds with symptoms of less than 36 h was conducted in which patients received ruprintrivir BID or TID or placebo for 10 days."}